Whether the lack of toxicity in MCF10A and RPE1 cells can solely be attributed to the presence of BRCA1 or whether it can also be partially explained by an overall decreased cellular uptake rate in normal versus cancer cells requires further investigation (36). The gene discussed is BRCA1; the disease is cancer.